About Me

Jeff Hartlin is a partner and chair of the Corporate practice of Paul Hastings in Palo Alto and is based in the firm’s Palo Alto and San Diego offices.

Mr. Hartlin concentrates his practice in corporate law, capital-raising, mergers & acquisitions and securities and has represented public and private companies in the software, hardware, information technology, biotechnology/biopharmaceutical, medical device, semiconductor, clean technology and financial industries. His experience in all aspects of the capital raising process includes representing issuers, underwriters, venture capital firms and placement agents in IPOs, registered directs, at-the-market offerings and rights offerings, as well as venture and angel-backed private placements, PIPEs, debt financings, Rule 144A transactions, reverse mergers, Regulation S offerings, and initial coin offerings (ICOs). Mr. Hartlin also routinely represents startup and other early-stage companies from incorporation through early financing, pre-IPO capital raising, IPO and eventual sale. Mr.Hartlin has represented several public and private companies in equity and debt private placements with a combined value of several billion. He also represents Nasdaq and NYSE companies with their periodic reporting requirements and listing qualification issues. He regularly advises boards of directors and management of public and private companies regarding corporate governance issues, including the Sarbanes-Oxley Act, the Dodd-Frank Act and the JOBS Act. Mr. Hartlin also represents public and private corporations in merger and acquisition transactions, joint ventures, leveraged and non-leveraged acquisitions, spinoffs, spin-ins and dispositions. He is frequently engaged to advise companies in activist stockholder matters.

Experience 

  • Integrated DNA Technologies, Inc. in its sale to Danaher Corporation
  • Shift Financial, Inc. in its merger with Ledge, Inc.
  • Mobile Gaming Technologies in its partnership with Arsenal Football Club
  • Menlo Technologies, Inc. in its acquisition of SSi Consulting
  • Redmile Group, LLC in its preferred stock financing of Alder BioPharmaceuticals, Inc.
  • Sorrento Therapeutics, Inc. and TNK Therapeutics, Inc. in their joint venture with Celularity, Inc.
  • Corsair Components in its sale to EagleTree Capital
  • Darmiyan, Inc. in its financing transaction
  • Mission Bio, Inc. in its venture-backed financing transaction led by Mayfield Ventures
  • Integrated DNA Technologies, Inc. in its partnership with Illumina
  • TNK Therapeutics, Inc. in its acquisition of Virttu Biologics
  • Sorrento Therapeutics, Inc. in its underwritten public offering
  • Zededa, Inc. in its financing transaction
  • Hummingbird Regtech, Inc. in its financing transaction
  • CareDx, Inc. in its debt financing by JGB Management Inc.
  • Tapclicks, Inc. in its debt financing by SaaS Capital
  • J.T. Posey Company in its sale to RoundTable Healthcare Partners
  • Biopop in its sale to Intrexon Corporation
  • Enplas America, Inc. in its equity and debt investments
  • JadeStream in its equity financing transactions
  • Matrix Industries, Inc. in its equity and debt financing transactions
  • Eprazel, Inc. in its strategic financing by Renren, Inc.
  • Sorrento Therapeutics, Inc. in its acquisition of Scilex Pharmaceuticals Inc.
  • &Beyond in the launch of its A2A Labs accelerator program
  • Seelos Therapeutics, Inc. in its licensing transaction with Ligand Pharmaceuticals Incorporated
  • CareDx, Inc. in its underwritten public offerings and its stock option exchange program
  • GenapSys, Inc. in its financing transactions
  • Health Expense, Inc. in its financing transaction
  • Hug Innovations Corp. in its financing transaction
  • myGini, Inc. in its financing transaction
  • Veriflow Systems, Inc. in its financing by Menlo Ventures and New Enterprise Associates (NEA)
  • Samumed, LLC in its financing transactions
  • SMA Solar Technology AG in its investment in Tigo Energy, Inc.
  • Filld, Inc. in its financings by Lightspeed Partners, Javelin Partners and PivotNorth
  • Plum, Inc. in its strategic financing by Renren, Inc.
  • Procera Networks, Inc. in its sale to Francisco Partners
  • Viking Therapeutics, Inc. in its initial public offering , follow-on public offerings and equity line financing
  • Kosei, Inc. in its sale to Pinterest, Inc.
  • Boomtown Networks, Inc. in its strategic financings
  • Sorrento Therapeutics, Inc. in its joint venture with NantWorks and financing transactions
  • RightSignature LLC in its sale to Citrix Systems
  • Integrated DNA Technologies, Inc. in the strategic financing by Summit Partners
  • Concortis Biosystems Corp. in its sale to Sorrento Therapeutics, Inc.
  • Samsung Electronics Co., Ltd. in the sale of its joint venture stake to, and strategic investment in, Corning Incorporated
  • Biopop in its financing and joint venture with Intrexon Corporation
  • Fox Factory in its initial public offering
  • YFind Technologies Private Limited in its sale to Ruckus Wireless, Inc.
  • Corsair Components, Inc. in the strategic financing by Francisco Partners and its acquisition of Simple Audio Limited
  • Transgenomic, Inc. in the debt financing by Third Security, LLC
  • Procera Networks, Inc. in its acquisition of Vineyard Networks Inc.
  • The underwriters, led by Goldman, Sachs & Co. and Deutsche Bank Securities, in the initial public offering of Envivio, Inc.
  • Monitise plc in its acquisition of ClairMail, Inc.
  • The underwriters, led by Stifel Nicolaus Weisel, in the public offering of Procera Networks, Inc.
  • Samsung Electronics Co., Ltd. in the sale of its hard disk-drive unit to Seagate Technology
  • Masimo Corporation in its acquisitions of Phasein AB and Spire Semiconductor, LLC
  • The underwriters, led by Stifel Nicolaus Weisel and Needham & Company, in the public offering of OCZ Technology Group, Inc.
  • Exceptional Cloud Services in its sale to Rackspace Hosting, Inc.
  • Aeolus Pharmaceuticals, Inc. in obtaining its grant from the Biomedical Advanced Research and Development Authority, a division of the Department of Health and Human Services
  • Samsung Electronics, Co., Ltd. in its acquisition of Nexus Dx
  • Houlihan Lokey as exclusive dealer-manager for Network Communications, Inc.’s senior notes exchange offer, consent solicitation and balance sheet restructuring
  • The investors of Hellosoft, Inc. in the company’s sale to Imagination Technologies plc.
  • Hanwha Chemical in its strategic investment in Solarfun Power Holdings
  • Mint Software, Inc. (mint.com) in its sale to Intuit, Inc.
  • Sybase, Inc. in its 144A-for-life convertible notes offering
  • AviaraDx, Inc. in its sale to bioMerieux
  • Masimo Corporation in its initial public offering
  • Warburg Pincus in its exchangeable bond investment in Synutra International, Inc.
  • Houlihan Lokey as the placement agent in the registered direct offering of ThermoGenesis Corp.
  • Outdoor Channel Holdings, Inc. in its follow-on public offering
  • CryoCor, Inc. in its initial public offering
  • The Titan Corporation in its acquisition of Jaycor, Inc. in a stock-for-stock merger
  • Favrille, Inc. in its initial public offering
  • Conexant Systems, Inc. in its stock option exchange program
  • MannKind Corporation in its initial public offering
  • Vical, Inc. in its public shelf offering
  • Applied Micro Circuits Corporation in its acquisition of JNI Corporation
  • Woodside Biomedical, Inc. in its sale to Abbott Laboratories
  • Captiva Software, Inc. in its merger-of-equals with ActionPoint, Inc.

Accolades And Recognitions

  • Mr. Hartlin was selected for inclusion in multiple editions of San Diego Super Lawyers
  • Mr. Hartlin was selected for inclusion in multiple editions of Southern California Super Lawyers
  • Mr. Hartlin was named a winner of the M&A Advisor 2012 (West) '40 Under 40' Award, which recognizes the emerging leaders of the M&A, financing, and turnaround industries
  • Chambers USA named Mr. Hartlin to multiple of its lists of leading lawyers in California capital markets transactions

Speaking Engagements And Publications

  • Mentioned in The Daily Journal and Law360 regarding Viking Therapeutics, Inc.'s initial public offering
  • Mentioned in The Recorder, The Daily Journal and Law360 regarding representing Kosei, Inc. its its sale to Pinterest, Inc.
  • Cheaper, Stronger IPOs Still Elusive After JOBS Act360
  • RR Donnelley presents to SEC Hot Topics Institute, San Diego, CA
  • Alliance Advisors, Society of Corporate Secretaries & Governance Professionals and Paul Hastings LLP present ISS Proxy Voting Guidelines, Chicago, IL
  • Society of Corporate Secretaries and Governance Professionals Presents Hot Issues in Private Company Governance, Colorado Springs, CO
  • RR Donnelley presents the SEC Hot Topics Institute, San Diego, CA
  • Paul Hastings, Citadel Securities, PricewaterhouseCoopers, MacKenzie Partners and RR Donnelley Present a Briefing on Proxy Access, Executive Compensation and Corporate Governance under the Dodd-Frank (Wall Street Reform) Act:
  • Paul Hastings, Houlihan Lokey, BDO Seidman and Thomas Weisel Partners Present a Briefing on Registered Direct and At-the-Market Equity Offerings: Trends for Raising Capital in 2010, Los Angeles, CA
  • RR Donnelley presents the SEC Hot Topics Institute, San Diego, CA
  • Stafford Publications presents: A Roadmap to Emerging Financing Alternatives Leveraging Opportunities in Rights Offerings, Registered Directs, and More
  • Houlihan Lokey, Paul Hastings and Sagient/PlacementTracker Present an Interactive Webinar: PIPEs: The Ever-Evolving Financing Technique

PROFESSIONAL AND COMMUNITY INVOLVEMENT

  • Member of the Board of Directors of the National Kidney Foundation of Northern California
  • Member of the California State Bar Association
  • Member of the Committee on Federal Regulation of Securities of the American Bar Association

Education

  • University of Virginia School of Law, J.D. (Editor-in-Chief of the Virginia Tax Review)
  • University of California Davis, B.A. (Phi Beta Kappa); NCAA Men's Varsity Soccer and Track & Field